Article History
Received: 18 April 2019
Accepted: 12 July 2019
First Online: 25 July 2019
Compliance with ethical standards
:
: Masaaki Ito received honoraria equal to or more than 500,000 yen from Daiichi Sankyo Company Limited, Bayer Holding Ltd., and Mitsubishi Tanabe Pharma Corporation in 2016, and from Daiichi Sankyo Company Limited, Bayer Holding Ltd., and Takeda Pharmaceutical Company Limited in 2017. The Department of Cardiology and Nephrology, Mie University Graduate School of Medicine was supported in part by unrestricted research grants of equal to or more than 1,000,000 yen from MSD K.K., Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Otsuka Pharma Inc., Daiichi Sankyo Company Limited, and Shionogi & Co., Ltd. in 2016, from Bristol-Myers Squibb K.K., MSD K.K., Shionogi & Co., Ltd., Otsuka Pharma Inc., Takeda Pharmaceutical Company Limited and Daiichi Sankyo Company Limited in 2017, and from Otsuka Pharma Inc. and Daiichi Sankyo Company Limited in 2018. Grants of 1,000,000 yen or more annually for research work (collaborative study, consignment study, or clinical trial), which the author is substantially authorized to use, were received from Daiichi Sankyo Company Limited in 2017 and 2018. The other authors declare that they have no conflicts of interest.